MAPT and Alzheimer disease: Studies in animal models of chronic cerebral hypoperfusion, such as the bilateral common carotid artery stenosis (BCAS) model10, converge with clinical studies in humans to show that chronic cerebral hypoperfusion accelerates AD pathology, including Aβ accumulation11–13, subsequent tau phosphorylation14,15, and eventual neuronal loss12.